
The Impact Of Technology On Clinical Trial Pipeline Assets
Luis Alvarez/DigitalVision via Getty Images By Alexandra Urman, Analyst As proposed in our previous research, investment analysts using antiquated throughput rates to determine future ones could be undervaluing clinical assets at each stage of development. […]